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Abstract
Whereas the majority of pathogenic Salmonella serovars are capable of infecting many different animal species, typically
producing a self-limited gastroenteritis, serovars with narrow host-specificity exhibit increased virulence and their infections
frequently result in fatal systemic diseases. In our study, a genetic and functional analysis of the mannose-specific type 1
fimbrial adhesin FimH from a variety of serovars of Salmonella enterica revealed that specific mutant variants of FimH are
common in host-adapted (systemically invasive) serovars. We have found that while the low-binding shear-dependent
phenotype of the adhesin is preserved in broad host-range (usually systemically non-invasive) Salmonella, the majority of
host-adapted serovars express FimH variants with one of two alternative phenotypes: a significantly increased binding to
mannose (as in S. Typhi, S. Paratyphi C, S. Dublin and some isolates of S. Choleraesuis), or complete loss of the mannose-
binding activity (as in S. Paratyphi B, S. Choleraesuis and S. Gallinarum). The functional diversification of FimH in host-
adapted Salmonella results from recently acquired structural mutations. Many of the mutations are of a convergent nature
indicative of strong positive selection. The high-binding phenotype of FimH that leads to increased bacterial adhesiveness
to and invasiveness of epithelial cells and macrophages usually precedes acquisition of the non-binding phenotype.
Collectively these observations suggest that activation or inactivation of mannose-specific adhesive properties in different
systemically invasive serovars of Salmonella reflects their dynamic trajectories of adaptation to a life style in specific hosts. In
conclusion, our study demonstrates that point mutations are the target of positive selection and, in addition to horizontal
gene transfer and genome degradation events, can contribute to the differential pathoadaptive evolution of Salmonella.
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Introduction
Salmonella enterica is comprised of six subspecies (I, II, IIIa, IIIb,
IV and VI) further subdivided into ,2,500 serovars based on the
presence of distinct surface antigens (somatic O, flagellar H and
capsular Vi). The vast majority of Salmonella strains pathogenic to
humans belong to subspecies I (S. enterica subsp. enterica), which is
considered to be adapted to warm-blooded animals unlike the
remaining subspecies which are found mostly in reptiles [1,2].
However, among ,1,500 serovars of subspecies I, relatively few
cause severe systemically invasive infections while most serovars
cause milder infections, usually limited to gastroenteritis. Hetero-
geneity in Salmonella virulence has been traditionally attributed to
different distributions of various mobile genetic elements such as
chromosomal pathogenicity islands, bacteriophages, transposons,
plasmids, etc. [3,4,5]. However, the distribution of these factors
does not correlate well with differences in clinical features. More
recently, gene loss via deletion, insertional inactivation or
truncation has been considered important in the evolution of
highly pathogenic Salmonella [6,7,8]. In this study, however, we
demonstrate that amino acid mutations in core genes of Salmonella
are also a driving force behind pathoadaptive evolution of
Salmonella serovars.
Various Salmonella serovars differ greatly in their host specificity
and pathogenicity. Many serovars can infect a broad spectrum of
animal hosts, typically producing self-limiting gastroenteritis (e.g.,
S. Enteritidis and S. Typhimurium). A small number of serovars
exhibit narrow host-specificity and show increased virulence in
their specific host that usually results in severe typhoid-like disease
[9,10]. For example, human adapted serovars Typhi, Paratyphi A
and, Paratyphi C cause typhoid fever exclusively in humans and
closely related primates. Avian adapted S. Gallinarum (biovars
Gallinarum and Pullorum) cause severe systemic diseases in birds
(fowl typhoid and pullorum disease respectively). Some other host-
adapted serovars such as Choleraesuis or Dublin, although
primarily associated with systemically invasive diseases in specific
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animal species including humans [11,12,13,14]. It is noteworthy
that in humans, infections with S. Choleraesuis and S. Dublin
typically lead to severe invasive disease [14,15,16]. Similarly the
D-tartrate negative biovar of Paratyphi B is primarily responsible
for paratyphoid in humans but can be also sporadically isolated
from dairy cattle [17,18]. In contrast, the broad-host spectrum D-
tartrate positive biovar of Paratyphi B (now biovar Java, formerly
serovar Java) causes gastroenteritis in humans.
The evolution of pathogenic Salmonella from a non-pathogenic
ancestor is primarily attributed to virulence genes acquired by
horizontal gene transfer [3]. This includes the acquisition of large
chromosomal regions (10–200 kbp) called Salmonella pathogenicity
islands (SPI) that contain a number of functionally related genes
[19]. Acquisition of small (,5 kbp) genetic loci, bacteriophages,
and plasmids also contribute to the evolution of virulence [4,5]. At
least five Salmonella pathogenicity islands (SPI-1 to 5) have been
identified in the serovars of S. enterica species, with a further nine
islands with characteristics of SPIs identified in genomes of
different serovars of subspecies I [20,21]. Although the molecular
effects of virulence traits encoded by these genetic loci have been
studied in detail, their distribution does not simply correlate with
host specificity or the level of systemic invasiveness of Salmonella
serovars. Recently, genome sequencing studies of host-adapted
serovars S. Typhi, S. Gallinarum, S. Choleraesuis and newly
emerging systemically invasive strains of S. Typhimurium in sub-
Saharan Africa revealed that these bacteria undergo extensive
gene deletion and truncation [6,7,8,22,23]. Because the majority
of lost genes have functional orthologs in systemically non-invasive
Salmonella with key roles in intestinal colonization, it has been
suggested that narrow host-adaptation of Salmonella co-evolved
with the loss of an intestinal life style and acquisition of the ability
to survive in a systemic niche [22].
While high-throughput comparative genomics of different
Salmonella strains have identified a large number of single
nucleotide polymorphisms (SNPs), very little is known about the
functional consequence of these sequence variations and their
potential impact on Salmonella ecology and pathogenicity
[24,25,26]. SNPs that represent random spontaneous mutations
in the coding or regulatory regions of genes can result in
modification or loss of gene function and/or expression [27].
These so called ‘change of function/loss of function’ mechanisms
can confer a strong selective advantage to bacteria during their
spread and growth in diverse host environments, improving their
survival or increasing their pathogenic potential and thus driving
their evolution toward an enhanced pathogenic phenotype.
Therefore they are referred to as pathoadaptive mutations [27].
A well characterized example of pathoadaptative mutation is
allelic variation in the FimH adhesin of type 1 fimbriae expressed
by uropathogenic Escherichia coli [28]. FimH mediates mannose-
sensitive bacterial adhesion to target cells [29]. It has been
demonstrated that uropathogenic isolates, due to structural point
mutations in fimH, express variants of FimH with an increased
capability to bind monomannose receptors, conferring a signifi-
cant advantage for colonization of the bladder compared to most
commensal E. coli [30,31].
Like E. coli, Salmonella have mannose-specific type 1 fimbriae
with a tip-associated adhesin also termed FimH [32,33]. Despite
functional and semantic similarity, the fimbriae in these two
species are not evolutionarily related, with virtually no significant
sequence homology, including fimH [34,35]. The FimH adhesin is
an excellent candidate for the study of evolutionary changes in
Salmonella adaptation. This adhesive protein has been reported to
play an important role in Salmonella adhesion and invasion
[36,37,38,39,40,41,42], and recently was shown to be a crucial
mediator of bacterial transcytosis through M-cells, a process which
is of great relevance in triggering the mucosal immune response
[43,44]. The expression of FimH on the bacterial surface is tightly
controlled by the fim regulatory proteins (FimZ, FimY and FimW)
in response to environmental signals [45,46,47] and, due to
involvement of fim regulatory proteins in the global regulatory
network, FimH expression is coupled with the expression of other
virulence factors including flagella [48], T3SS [49,50,51] and LPS
[52]. Thus, it can be expected that diversity of host cell receptors,
the host immune response and other indirect mechanisms exert
differential selective pressures on FimH adhesins during different
types of Salmonella infection.
Recent studies on FimH adhesins of S. Typhimurium demon-
strated that there is allelic variability of FimH, where single amino
acid substitutions increase bacterial binding to human HEp-2 and
murine DC cells, and increase efficiency of biofilm formation in
the small intestine of mice [38,53]. Also, in S. Gallinarum (biovars
Pullorum and Gallinarum), FimH variants have lost the ability to
mediate mannose-sensitive adhesion due to a single point mutation
that eliminates mannose binding [54]. However, the general
pattern of FimH variability across different serovars of Salmonella is
unknown, and it is not established whether point mutations in
FimH are acquired under positive selection and thus are likely to
contribute to the evolution of virulence in Salmonella, especially in
strains capable of invasive infections.
To determine whether point mutations in FimH are associated with
pathoadaptive evolution of specific Salmonella serovars, we performed
genetic and functional analyses of FimH adhesin variants from 33
serovars of S. enterica.We found that FimH inhost-adapted (systemically
invasive) serovars evolve in a convergent way, both structurally and
functionally, highlighting the role of point mutations in the differential
adaptive evolution of Salmonella.
Results
The phylogenetic relatedness of fimH genes within S.
enterica
fimH was amplified from 55 of 56 S. enterica isolates, of which 45
represented 22 serovars of subspecies I, and 11 isolates represented
Author Summary
The process of Salmonella host-adaptation is traditionally
considered to involve acquisition of novel genetic elements
encoding specific virulence factors or loss of genes
representing liability for the more pathogenic strains. Here,
by analysis of the mannose-sensitive fimbrial adhesin FimH,
we demonstrate that in addition to horizontal gene transfer
and genome degradation, single amino acid replacement
playsanimportantrole inthe differentialadaptiveevolution
ofSalmonella.Weshowthatacquisitionofspecificstructural
mutations in FimH variants of host-adapted (systemically
invasive) serovars results in either significantly enhanced or,
alternatively, completely inactivated mannose-binding,
whereas systemically non-invasive serovars retain a primor-
dial relatively low-binding (shear-dependent) phenotype. A
phylogenetic analysis indicates that these mutations are
commonly of a convergent nature and occur under strong
positive selection illustrating the role of point amino acid
changes in convergent evolution of host-adapted Salmo-
nella. Although we show increased bacterial adhesiveness
and cell-invasiveness of the high-binding mutants, the
physiologic role of the non-binding mutations in FimH
remains to be determined.
Pathoadaptive FimH Mutations in Salmonella
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(2980) carried only part of the fimH gene and was excluded from
further analysis. The maximum-likelihood phylogenetic tree
constructed based on 55 amplified fimH sequences and five
additional fimH alleles obtained from GenBank (fimH of S.
Typhimurium AJB3 and LB5010, S. Gallinarum 287/91 and
589/02, and S. Paratyphi C 49 [RKS 4594]) is presented in
Figure 1A. The fimH sequences of subspecies I (enterica) were
grouped in a distinct phylogenetic clade separate from fimH of
subspecies II–VI, which were also separated from one another
(with bootstrap values for branch separation higher than 60%).
fimH phylogeny was compared to the phylogenetic relationship
of the study strains based on their Multi-Locus Sequence Typing
(MLST) profiles by using concatenated sequences of three
housekeeping genes aroC, hisD and thrA (Figure 1B). Strains
belonging to same serovars had the same, usually distinct, MLST
profiles and there was a general congruency between the fimH and
MLST trees. In particular, different subspecies of S. enetrica were
split into distinct clades on both fimH and MLST trees and, within
subspecies I, the fimH phylogeny of serovar clades like Typhi and
Paratyphi A, Choleraesuis and Paratyphi C, or Pullorum,
Gallinarum, and Enteritidis corresponded well with MLST
genotype. Also within the subspecies I, fimH of the same serovars
were grouped together, suggesting limited horizontal transfer of
fimH among different serovars. However, there was less congru-
ency between the serovar clades defined by fimH and MLST,
indicating that, in general, fimH of different host-adapted,
systemically invasive serovars have evolved along independent,
phylogenetically unlinked pathways.
Structural variability of S. enterica subspecies I FimH
The average nucleotide diversity of fimH from S. enterica
subspecies I was 1.760.2%, with 28 distinct alleles. The majority
of the nucleotide polymorphisms were point mutations with a
seven-fold higher rate of synonymous over nonsynonymous
mutations. The only other polymorphism type was a three-
nucleotide insertion (aat) between nucleotide position 864 and 865
in three fimH alleles of Paratyphi B (PaB1, PaB2 and PaB3). There
were a total of 27 protein variants encoded by fimH with an overall
protein level identity of 96.6% (Figure 2). There were 45 amino
acid replacements in the 335 amino acid polypeptide and an
asparagine insertion between positions 266 and 267 in Paratyphi B
FimH variants. The majority of serovars contained unique FimH
variants, but some serovars, e.g., Montevideo and Muenchen;
Paratyphi A and Sendai; or Poona, Limete and Pomona, shared
the same protein variants of FimH (Figure 2). For some serovars,
e.g. Paratyphi B, Choleraesuis and Gallinarum, within-serovar
variability of FimH was observed. FimH variations affected the
putative leader peptide (22 aa long) as well as a predicted
mannose-binding lectin domain (N-terminal 173 aa in the mature
protein) and shaft-anchoring pilin domain (C-terminal 136 aa).
There was no significant domain clustering or predominance of
either conservative or nonconservative protein changes among
FimH variants overall or between FimH from systemically invasive
and non-invasive serovars (Figure 2).
When the FimH protein variants were analyzed for emergence
from an evolutionary perspective, most FimH variants (20 out of
27) appeared to have emerged relatively recently, without
accumulation of silent changes in the coding alleles (Figure 3).
The rest of the FimH variants were of a relatively long-term
evolutionary origin, with accumulation of silent changes in the
corresponding alleles or along the surrounding branches on the
tree. Interestingly, while the systemically non-invasive serovars
included nine recent and six long-term FimH variants, only one of
twelve FimH variants from systemically invasive serovars was of
long-term origin (p=0.04). Moreover, alleles of the majority (10 of
12) of FimH variants from systemically invasive serovars evolved
from the nearest allele exclusively by structural mutations.
Thus, while the overall pattern of distribution of FimH
variations was not strikingly different between systemically invasive
and non-invasive serovars, the evolutionarily recent origin and
structural nature of the fimH mutations appeared to be much more
typical for the systemically invasive serovars.
High-adhesive and inactive variants of FimH are selected
in systemically invasive serovars of S. enterica
We next compared functional properties of different structural
variants of FimH by examining the level of bacterial binding to
Mannose-BSA (Man-BSA) in an isogenic system. Man-BSA, used
as model substrate, contains single (mono-) mannose residues,
Man1, covalently coupled to BSA. As controls for assessing the
level of binding, we used a fimH-knockout variant (fimHD) as well
as three structural variants of S. Typhimurium FimH character-
ized previously: a relatively low-binding variant of S. Typhimur-
ium SL1344 (Thm1) and two high-binding variants from strains
AJB3 (Thm3) and 5010 (Thm4) [38,53,55] (Figure 4). The
majority of FimH variants exhibited relatively low but specific
(.95% mannose-inhibitable) binding to Man-BSA (Figure 4 and
data not shown). However, with the exception of FimH from S.
Paratyphi A/Sendai, all of the low binding FimH variants came
from systemically non-invasive serovars of S. enterica. In contrast, all
high-binding FimH variants were from systemically invasive
serovars such as Typhi (strains Typ1–Typ4), Paratyphi C
(PaC1), and Choleraesuis (strains Chl5–Chl6). Also, FimH from
another systemically invasive serovar Dublin (Dub1–Dub7) bound
Man-BSA significantly stronger than low-adhesive FimH variants,
though the binding was weaker in comparison to the other high-
binding FimH variants. The binding differences were not due to a
difference in the expression level of FimH, as bacteria expressing
different variants of FimH bound relatively well to polyclonal anti-
FimH antibody (Figure 4). Interestingly, FimH variants expressed
by the remainder of the invasive strains did not exhibit detectable
mannose-specific binding to Man-BSA, and also failed to bind
Man5 oligosaccharides carried by ribonuclease B (RNase B,
Figure S1), to which all functionally-active FimH variants bind
with much higher affinity than Man1 ligands [55]. However, they
still retained their interaction with anti-FimH antibodies (Figure 4).
Such an ‘inactive’ FimH phenotype may be similar to that shown
previously for FimH variants of S. Gallinarum biovars Pullorum
(Figure 4 and Figure S1) and Gallinarum ([54], not tested in this
study).
We also performed the static adhesion assay to examine
mannose-dependent binding of wild type strains of Salmonella.A s
presented in supplementary Figures S2 A and B, the mannose-
binding pattern of wild type strains corresponded to the binding
pattern of FimH variants expressed in isogenic recombinant
system. The wild-type Salmonella carrying fimH alleles encoding
low-binding FimH exhibited relatively weak binding to mono-
mannose substrate (Man1) and bacteria with ‘high-binding’ fimH
alleles adhered strongly to monomannose (Figure S2 B, red bars).
Wild-type isolates with non-binding fimH alleles did not adhere to
any of the mannosylated substrates tested (Man1 and Man5). The
differences in the level of mannose-specific adhesion between these
three groups of wild-type Salmonella were clear, even though
variability in the fimbriation level was observed (Figure S2, grey
bars). A reduced level of fimbriation was found particularly for
isolates of serovar Choleraesuis (Figure S2) while isolates of
Partyphi A and Sendai from this study did not produce fimbriae at
Pathoadaptive FimH Mutations in Salmonella
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Strain Strain tag
Strain origin/characteristic relevant for this study
(year of strain isolation) Reference/source
Wild-type:
S. Typhimurium SL1344 Thm1 Bovine [96]
S. Typhimurium 1 (RKS4194) Thm2 Human, England [97]
S. enterica serogroup B C-24 Thm5 Human stool, recurrent gastroenteritis/typhoid fever, (2007) * F. Fang
1
S. Pomona DMSO63 Pom1 Unknown [98]
S. Anatum DMSO13 Ant1 Unknown [98]
S. Dublin DMSO30 Dub1 Unknown [98]
S. Dublin C-29 Dub2 Human blood, colitis/sepsis, (2011) F. Fang
S. Dublin 10351 Dub3 Bovine (necropsy) (2006) M. Samadpour
2
S. Dublin 11170 Dub4 Bovine spleen (2006) M. Samadpour
S. Dublin 11087 Dub5 Bovine lung (2006) M. Samadpour
S. Dublin 10928 Dub6 Bovine feces (2006) M. Samadpour
S. Dublin 10828 Dub7 Bovine necropsy (2006) M. Samadpour
S. Mississippi DMSO49 Msp1 Unknown [98]
S. Agona DMSO09 Ago1 Unknown [98]
S. Newport DMSO55 New1 Unknown [98]
S. Pullorum SL297 Pul1 Unknown [98]
S. Paratyphi B S66 PaB1 Unknown [74]
S. Paratyphi B S957 PaB2 Unknown [74]
S. Paratyphi B 2421 PaB3 Unknown S. Clegg
3
S. ParatyphiB var java DMSO45 PaB-j1 Unknown [98]
S. Enteritidis 11122-1 Ent1 Avian M. Samadpour
S. Enteritidis 12154-1 Ent2 Bovine (environmental) M. Samadpour
S. Choleraesuis x3246 Chl1 Porcine [99]
S. Choleraesuis 10411-1 Chl2 Bovine lung (necropsy) M. Samadpour
S. Choleraesuis 11175-1 Chl3 Porcine lung (necropsy) M. Samadpour
S. Choleraesuis 11359-1 Chl4 Porcine (necropsy) M. Samadpour
S. Choleraesuis 1656/04 Chl5 Porcine M. Ugorski
4
S. Choleraesuis 1500/05 Chl6 Porcine M. Ugorski
S. Typhi 63 (RKS3333) Typ1 Dakar [100]
S. Typhi 64 (RKS3320) Typ2 Dakar [100]
S. Typhi C-23 Typ3 Human blood, typhoid fever (2002) F. Fang
S. Typhi Ty2 (JSG624) Typ4 Unknown J. Gunn
5
S. Paratyphi A 42 (RKS4993) PaA1 Laboratory strain (ATCC 9150) [100]
S. Sendai 58 (RKS2866) Sen1 Human, California [100]
S. Limete 47 (RKS3215) Lim1 Human, Africa [100]
S. Indiana 25 (RKS4250) Ind1 Scotland [100]
S. Muenchen 32 (RKS3121) Mun1 Laboratory strain (ATCC 8388) [100]
S. Montevideo 30 (RKS1762) Mon1 Human, Georgia [100]
S. Montevideo 31 (RKS 1740) Mon2 Human, Florida [100]
S. Wien 71 (RKS4000) Wie1 Human, France [100]
S. Poona MI14a Poa1 Marine Iguana, S. Plaza, Galapagos R.I. Mackie
6
S. Panama LI03e Pan1 Land Iguana, S. Plaza, Galapagos R.I. Mackie
S. Sandiego MI08d San1 Marine Iguana, S. Plaza, Galapagos R.I. Mackie
S. Sandiego LI23b San2 Land Iguana, Santa Fe, Galapagos R.I. Mackie
S. Sandiego LI010a San3 Land Iguana, S. Plaza, Galapagos R.I. Mackie
S. enterica subsp. II (RKS 2993) 2993 Unknown [97]
S. enterica subsp. IIIa (RKS 2980) 2980 Corn snake, Oregon [97]
S. enterica subsp. IIIa (RKS 2983) 2983 Human, California [97]
Pathoadaptive FimH Mutations in Salmonella
PLoS Pathogens | www.plospathogens.org 4 June 2012 | Volume 8 | Issue 6 | e1002733all (data not shown). Nevertheless, the fimbriated wild-type and
recombinant strains displayed the same receptor specificity of
binding as assessed by determination of the Man1/Man5 binding
ratio (Figure S3).
Selected FimH variants with a range of binding activities (Typ1,
PaC1, San1, Chl1 and Pul1) were further analyzed in Man-BSA
binding under flow conditions (Figure S4). FimH variants with
low-binding phenotypes mediated shear-enhanced (shear-depen-
dent) adhesion to Man-BSA, whereas FimH variants with high-
binding phenotypes bound to Man-BSA in a shear-independent
manner. Bacteria expressing non-binding variants of FimH did not
exhibit binding to Man-BSA under any flow conditions. These
results indicate that the low-binding shear-activated phenotype of
FimH is predominant among systemically non-invasive serovars of
S. enterica, while high-adhesive shear-independent or inactive FimH
variants occur only in systemically invasive serovars of Salmonella.
FimH of systemically invasive Salmonella evolved by
accumulation of ‘‘activating’’ and/or ‘‘inactivating’’ point
mutations
We compared amino acid sequences of high-binding and
inactive FimH variants with their closest FimH ancestors
exhibiting low-binding phenotypes (Figure 1). According to the
fimH phylogeny, the low-binding phenotype is evolutionarily
ancestral to the high-binding FimH and, in most cases, non-
binding variants evolved from high-binding variants (Figure 5). For
example, high-binding variants of FimH of S. Paratyphi C and S.
Choleraesuis (Chl5–Chl6) evolved from the low-binding variant of
S. Indiana; and the non-binding FimH of S. Choleraesuis (Chl1–
Chl4) evolved from the high-binding FimH of S. Choleraesuis
(Chl5–Chl6). In the case of S. Paratyphi B, the whole spectrum of
phenotypes evolved within the serovar. The non-binding pheno-
type of S. Gallinarum biovar Pullorum appeared to evolve from
low-binding variants of S. Enteriditis, with the former then giving
rise to two non-binding FimH variants of S. Gallinarum biovar
Gallinarum. Interestingly, with the exception of S. Typhi FimH,
all microevolutionary changes in the gene observed in systemically
invasive serovars occurred exclusively via amino acid replace-
ments, i.e., without accumulation of any silent mutations,
suggesting the action of strong positive selection. In addition,
some of the mutations occurred repeatedly (P35L, T56I) or in the
same amino acid position (V41G and V41C) indicating conver-
gent evolution of the FimH variants, also a strong indicator of
positive selection. Importantly, the evolutionary changes of the
fimH variants correspond to serovar phylogeny based on MLST
data (Figure 5, light orange boxes).
The naturally occurring mutations were separately introduced
into a plasmid-encoded S. Typhimurium SL1344 (Thm1) fimH
(low-binding phenotype) and assayed for functional effects in the
isogenic S. Typhimurium LBH4 strain. In the isogenic system, a
switch from low- to high-binding phenotype was observed for the
single mutations N79S (Ent1/Ent2 to Dub1–Dub72), P35L and
R232W (Ind1 to Chl5/Chl6 and to PaC1, respectively) and the
N266/267 insertion (PaB-j1 to hypothetical PaB variant) (Figure
S5 and Figure 5). Mutation T56I resulted in a change from low-
(Ent1/Ent2) to non-binding phenotype (Pul1), while a high- to
non-binding switch was confirmed for T56I, M105I and G106D
(all in S. Paratyphi B) as well as V41G in S. Choleraesuis. Notably,
the non-binding mutation V41G had a deleterious effect on
bacterial fimbriation when introduced directly into the low-
binding FimH test background (S. Typhimurium SL1344).
However, when this mutation was introduced into the high-
binding P35L background of its immediate ancestor, fimbriation
was normal as indicated by anti-FimH antibody binding while the
binding function was lost (Figure S5). When the multiple
mutations leading from the low-binding phenotype of S. Paratyphi
A/Sendai FimH to the high-binding FimH of S. Typhi were tested
individually, three mutations resulted separately in a high-binding
phenotype: P35L (as in Chl5–Chl6), G39D and M137I (Figure
S5). In contrast, mutations E36K and V41C resulted individually
in a significantly decreased or a non-binding phenotype, respec-
tively. Unlike V41G in S. Choleraesuis, the V41C substitution did
not eliminate fimbriation in the FimH test background.
Table 1. Cont.
Strain Strain tag
Strain origin/characteristic relevant for this study
(year of strain isolation) Reference/source
S. enterica subsp. IIIb (RKS 2978) 2978 Human, Oregon [97]
S. enterica subsp. IIIb (RKS 2979) 2979 Human, California [97]
S. enterica subsp. IV (RKS 3015) 3015 Animal, Canal zone [97]
S. enterica subsp. IV (RKS 3027) 3027 Human, Illinois [97]
S. enterica subsp. IV (RKS 3013) 3013 Tonga-T1 [97]
S. enterica subsp. IV (RKS 3014) 3014 Human, Florida [97]
S. enterica subsp. VI (RKS 2995) 2995 India [97]
S. enterica subsp. VI (RKS 3057) 3057 Unknown [97]
Recombinant: [97]
S. Typhimurium SL1344H3 - fimH::kan mutant of S. Typhimurium SL1344 [38]
S. Typhimurium LBH4 - fimH::kan mutant of S. Typhimurium LB5010 [101]
S. Typhi Ty57 Typ4 aroA::kan mutant of S. Typhi Ty2 This study
1Harborview Medical Center, Seattle, WA, USA.
2Institute for Environmental Health, Lake Forest Park, WA, USA.
3University of Iowa, Iowa City, IA, USA.
4Wroclaw University of Environmental and Life Sciences, Wroclaw, Poland.
5Ohio State University, Columbus, OH, USA.
6University of Illinois, Urbana, IL, USA.
doi:10.1371/journal.ppat.1002733.t001
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binding phenotypes of FimH in systemically invasive serovars of S.
enterica are acquired under positive selection by convergent
evolution, with inactivation of FimH generally preceded by
evolution of the high-binding phenotype.
FimH variations affect adhesion to and internalization
into epithelial cells and macrophages
We investigated how variation in mannose-binding by Salmonella
FimH affects bacterial cell adhesion and invasion. The human
epithelial cell line HEp-2 and the murine macrophage cell line
RAW264.7 were used as target cells. We compared isogenic
strains that express two previously characterized S. Typhimurium
FimH variants, low-binding FimH
SL1344 (Thm1) and high-binding
FimH
AJB3 (Thm3), that differ in a single amino acid N136Y, and
FimH variants from five other serovars: Enteritidis (Ent1, low-
binding), Dublin (Dub1, medium-binding), Choleraesuis strain
Chl5 and Typhi strain Typ1 (both high-binding), and Choleraesuis
strain Chl1 (non-binding). Bacterial adhesion and invasion were
assessed after allowing a bacterial suspension to interact with the
target cell monolayers under static conditions without centrifuga-
tion. As shown in Figure 6, the level of bacterial binding to both
epithelial cells (6A) and macrophages (6C) corresponded well to
the mannose-binding capability of the FimH variants, with the
high-binding FimH mediating up to 10-fold higher adhesion than
the low-binding variants and up to 100-fold higher adhesion than
inactive FimH of Choleraesuis (Chl1) or the FimH knockout strain
that does not express type 1 fimbriae (fimHD). The binding was
strongly inhibited by a soluble mannose derivative (methyl-alpha-
D-mannopyranoside). Thus, under our experimental conditions
cell adhesion is primarily mediated by FimH, and the variants with
activating mutations mediate significantly better cell binding.
When bacterial internalization was assessed (Figure 6B and D), the
pattern generally was the same. Consequently, the highly-adhering
bacteria were internalized to a significantly higher degree than the
low-adhering bacteria. However, while the level of FimH-
dependent bacterial adhesion to these two types of eukaryotic
cells was similar, the invasion level differed significantly with 75
times greater invasion of the macrophage cell line (7.4–13.2% of
bacterial inoculum) compared to the epithelial cells (0.07–0.19%
of bacterial inoculum). Again, invasion was strongly inhibited by
soluble mannose.
Figure 1. Maximum-likelihood DNA phylograms of S. enterica fimH and concatenated MLST loci (aroC, hisD and thrA). The fimH tree (A)
was built based on an alignment of fimH sequences amplified from 55 isolates including 45 different strains of subspecies I and 10 strains of
subspecies II–VI (for details see Table 1). Five additional alleles of fimH obtained from GenBank (S. Typhimurium AJB3 (Thm3), S. Typhimurium LB5010
(Thm4), S. Gallinarum 287/91 (Gal1) and 589/02 (Gal2), and S. Paratyphi C 49 [RKS4594] (PaC1) were included. The MLST loci tree (B) was built on an
alignment of concatenated sequences of three genes (aroC, hisD and thrA) obtained for 57 study strains. The trees shown were rooted using S.
enterica subsp. II (2993). The italicized values along the branches denote % bootstrap values based on 1000 runs (the bootstrap proportions along the
terminal branches separating isolates within single serovars as well as the ones below 50% are not shown). Systemically invasive serovars are shown
in red and non-invasive serovars are shown in black. Strain tags are as used in the text.
doi:10.1371/journal.ppat.1002733.g001
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observed for bacteria expressing different FimH variants, no
differences in viable bacterial counts from spleen and liver were
observed 7 days after oral inoculation of BALB/c mice with
Salmonella strains expressing FimH variants (data not shown).
Discussion
In the present study, we have demonstrated that the FimH
adhesin in highly pathogenic (systemically invasive) S. enterica
serovars undergoes convergent evolution via point mutations that
are likely to have adaptive significance for Salmonella ecology and
pathogenesis. We have shown that the shear-dependent low-
binding phenotype of FimH is preserved in serovars typically
associated with gastroenteritis, whereas the majority of systemi-
cally invasive serovars carry FimH variants that exhibit one of two
alternative but evolutionarily-interconnected phenotypes: in-
creased affinity towards mannose or the outright loss of the
mannose-binding activity. The functional diversification of FimH
in systemically invasive Salmonella results from repeated, indepen-
dently acquired structural mutations showing that, in addition to
horizontal gene transfer and gene deletion, point mutations are the
target of strong positive selective pressure and contribute to the
pathoadaptive evolution of Salmonella.
While separation of Salmonella into systemically invasive, host-
adapted and systemically non-invasive, broad host-range serovars
may seem somewhat arbitrary, this distinction is generally
consistent with prevailing views on Salmonella ecology and
epidemiology [9,10]. Subspecies II–VI of Salmonella (salamae,
arizonae, diarizonae, houtenae, and indica) that are almost exclusively
isolated in nature from reptiles only sporadically cause infections in
humans [1,2,56]. Subspecies I (enterica) is much more pathogenic
for humans than the other five subspecies and is typically isolated
from warm-blooded animals. However, the ecology of subspecies I
serovars is not as distinct as originally thought, as many (e.g.
Poona, Pomona, Abaetetuba, Newport), commonly inhabit wild
reptiles, often as dominant Salmonella serovars [57]. Some of the
subspecies I strains tested here (serovars Poona, Panama and
Sandiego) were isolated from free-living marine or land iguanas
from the Galapagos Islands. Thus, many and probably most of the
subspecies I serovars truly have a broad range of natural hosts, not
limited to warm-blooded animals. However, other serovars such as
Typhi, Paratyphi A–C and Choleraesuis are much more distinct in
their host association and ability to cause systemic (invasive)
disease relative to other serovars of subspecies I. Interestingly, the
distinct structural and functional characteristics of FimH in the
serovars defined here as systemically invasive support the
physiologic validity of their grouping.
Figure 2. Amino acid variation in S. enterica subspecies I FimH. Residues identical to the amino acid sequence of S. Typhimurium SL1344
(Thm1) FimH are indicated by dots. Systemically invasive serovars are shown in red and non-invasive serovars are shown in black. Position -10
represents the position in the signal peptide of unprocessed FimH upstream of the cleavage site.
doi:10.1371/journal.ppat.1002733.g002
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bioinformatics-based approach called Zonal Phylogeny that is
highly sensitive in detecting footprints of positive selection,
superior in this regard to more conservative tests such as the
dN/dS ratio [28,58]. Zonal Phylogeny detects an excess of
recently evolved protein variants and determines whether or not
they evolved via hot-spot mutations (repeated changes in the same
amino acid positions). Both parameters are indicative of the
source-sink dynamics of adaptive evolution, in which the source is
an evolutionarily primary reservoir habitat for a species and the
sink is a novel and/or secondary habitat [59]. It has been
hypothesized that source-sink dynamics is one of the major types
of evolutionary trajectory in highly-pathogenic bacterial lineages
within less pathogenic species. FimH of systemically non-invasive
Salmonella were found to have accumulated synonymous mutations
(with or without non-synonymous changes), whereas the majority
of systemically invasive Salmonella FimH variants evolved exclu-
sively by the accumulation of structural mutations, reflecting the
recent origin of the latter. While structural mutations accompanied
by synonymous mutations indicate neutral accumulation of
changes, differentiation of genes exclusively through structural
mutation is strong evidence of positive selection. Furthermore, the
recent mutations in FimH frequently were found to be repeated
hot-spot mutations, i.e. of an evolutionarily convergent nature -
another strong indication that they are under positive selection
and, thus, functionally adaptive.
Functional analysis of Salmonella FimH revealed that structural
variability is associated with diverse binding properties of the
adhesin, also of convergent nature, in the systemically invasive
serovars. While all tested FimH variants from broad-host range
serovars of S. enterica exhibited low binding to mannose under static
conditions, FimH of host-adapted serovars had altered functional
properties. FimH from systemically invasive serovars Typhi,
Paratyphi C, Dublin, and some isolates of serovar Choleraesuis
exhibited significantly increased binding to mannose, whereas
some other FimH variants of systemically invasive serovars
Figure 3. DNA-based protein phylogram of S. enterica FimH, derived from ZP analysis. The tree was built based on the 50 fimH sequences
of S. enterica subsp. I. Each circle represents a unique structural variant, and the size of the circle is proportional to the number of representative
sequences. The dashed line separates the long-term (green) from the recently emerged variants (black). Branches marked in blue indicate branches
containing synonymous mutations. The length of each branch is proportional to the number of non-synonymous mutations that were acquired. The
strain tags of systemically invasive serovars are in red and the non-invasive serovars in black.
doi:10.1371/journal.ppat.1002733.g003
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PLoS Pathogens | www.plospathogens.org 8 June 2012 | Volume 8 | Issue 6 | e1002733Figure 4. Binding phenotypes of natural S. enterica subspecies I FimH variants. Static adhesion of S. Typhimurium LBH4 transformed with
plasmids encoding different variants of FimH or plasmids carrying fimH deletion (fimHD) to Man-BSA (red bars) and anti-FimH
SE antibody (grey bars).
The binding of
3H- labeled bacteria was determined as described in Material and Methods. Data are the means 6 SD of triplicates from one
representative experiment of three experiments that were performed. The strain tags of systemically invasive serovars are in red and the non-invasive
ones in black. Bacterial binding was .95% inhibitable in the presence of 50 mM methyl-D-mannopyranoside (not shown). * The non-binding FimH
variants of S. Gallinarum were not tested in this study.
doi:10.1371/journal.ppat.1002733.g004
Figure 5. Schematic representation of evolutionary changes in the FimH binding phenotype of selected S. enterica serovars. The
evolutionary changes in the FimH of S. Enteritidis, S. Pullorum, S. Gallinarum and S. Dublin (A), S. Indiana, S. Paratyphi C and S. Choleraesuis (B), S.
Paratyphi B (C) and S. Paratyphi A, S. Sendai and S. Typhi (D). Low (green)-FimH with low-binding phenotype; High (blue)-FimH with high-binding
phenotype; None (orange)-inactive variant of FimH. The strain tags of systemically non-invasive serovars are in black and the systemically invasive
serovars in red. Structural mutations are given along each arrow. Structural hot-spot mutations are underlined. The activating mutations are in blue
and the inactivating mutations are in orange. The FimH variants from strains with phylogenetic relatedness supported by MLST are shown in tan
boxes.
doi:10.1371/journal.ppat.1002733.g005
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the high-binding and non-binding phenotypes evolved, in part, via
hot-spot mutations in different systemically invasive serovars. Of
note, FimH variants of gastroenteritis–associated serovars, though
differing from each other by various structural mutations,
preserved low-adhesive properties suggesting the physiological
importance of the low-binding FimH phenotype in the intestinal
niche.
The low-binding phenotype was found to be significantly
increased under shear stress, i.e., shear-enhanced in nature. This
phenomenon was originally demonstrated for E. coli FimH and
then for several other fimbrial tip-associated adhesins of entero-
bacteria, including Salmonella FimH (evolutionarily unrelated to E.
coli FimH) [55,60,61,62,63]. The phenotype is based on an
allosteric connection between the mannose-binding pocket in the
lectin domain of the adhesin and the fimbria-anchoring pilin
domain of FimH. When the domains separate from one another
under shear-induced tensile force, the binding pocket converts
from a wide-open to a tight configuration, increasing the binding
affinity for mannose [64]. In contrast, the high-binding phenotype
(as observed here for systemically invasive Salmonella) is shear-
independent in nature, with already strong binding under low or
no shear conditions and no enhancement of binding under shear
stress. In E. coli FimH, the high-binding protein variants carry
mutations in either lectin or pilin domains that ease the inter-
domain interaction [65]. This explains why the high-binding
phenotype mutations in Salmonella are found both in the predicted
lectin (P35L, G39D and M137I) and pilin (R232W and insertion
266/267N) domains. In contrast, the non-binding phenotype
mutations are found only in the lectin domain. Notably, the non-
binding phenotype of Salmonella FimH could not be rescued under
increased shear, indicating that they might directly affect the
function of the mannose-binding pocket.
While the evolutionarily adaptive origin of the FimH mutations
in systemically invasive Salmonella serovars is evident from the
action of positive selection, and there are hints to their structural
basis, the physiological significance of the mutations remains an
open question. In E. coli, high-binding mutations that are selected
in uropathogenic strains were shown to increase urothelial
adhesion and colonization in a mouse model of infection [31].
One might speculate that in Salmonella, increased cell adhesiveness
may also be adaptive for systemically invasive serovars. In
gastroenteritis, bacterial infection remains localized to the intestine
and mesenteric lymph nodes, while in systemic infections,
Salmonella transverses the intestinal barrier and disseminates to
the liver, spleen and bone marrow. A critical determinant of
systemic dissemination of Salmonella is its ability to infect dendritic
cells and other CD18-positive phagocytes [66,67]. Recent studies
of Guo at al. (2007) [39] demonstrated that Salmonella uptake by
dendritic cells can be mediated by FimH, and the high-binding
Figure 6. FimH-mediated bacterial interaction with epithelial and macrophage cell lines. Bacterial adhesion to (A and C) and invasion of
(B and D) Hep-2 cells (A and B) and RAW264.7 cells (C and D). Different variants of FimH were expressed in S. Typhimurium SL1344H3 and bacterial
binding was tested in the absence and presence of 50 mM methyl-D-mannopyranoside (a-mm). Data are the means 6 SD of triplicates from one
representative experiment of three experiments that were performed.
doi:10.1371/journal.ppat.1002733.g006
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extremely efficient in mediating bacterial internalization into
murine cells. Consistently, we found that FimH variants from
serovars Typhi, Choleraesuis and Dublin with increased affinity
towards mannose confer significantly higher adhesion to and
internalization of macrophage cell line RAW 264.7 than low-
binding FimH variants. Moreover, the level of RAW264.7 cell
internalization mediated by these FimH variants was on average
seventy five times higher than internalization of epithelial cells
(Hep-2), although the level of bacterial adhesion to both of the cell
types was comparable. This indicates that FimH is important
factor determining bacterial entry into phagocytic cells but not
into epithelial cells for which FimH-dependent internalization was
only marginal. These results are consistent with previous reports
demonstrating that SPI-1 encoded T3SS is the major invasive
factor for epithelial cells whereas the invasion of phagocytic cells is
rather SPI-1-T3SS independent [39,68]. Although the effect of
FimH-mediated entry of Salmonella on its intracellular survival into
phagocytic cells has not been analyzed, similar studies performed
in E. coli indicate that this route of internalization can promote
bacterial survival. It was shown that FimH-dependent uptake of E.
coli by mouse macrophages results in the formation of morpho-
logically distinct bacteria-containing vacuoles, compared to
antibody-opsonized E. coli, correlating with a significant increase
in intracellular survival [69,70,71]. Thus, highly adhesive variants
of FimH with increased capability to mediate internalization in
phagocytes could be advantageous for the systemic dissemination
of host-adapted Salmonella serovars.
Another important step in Salmonella pathogenesis is the
traversing of M cells, whose apical membranes are rich in
transcytotic receptor-glycoprotein 2 (GP2), a mannosylated
glycoprotein that acts as a receptor for FimH [43,44]. Although
FimH variation in bacterial uptake and transcytosis by M-cells has
not been studied, it is possible that allelic variations could affect
bacterial delivery to deeper tissues (including Peyer’s patches) and
alter Salmonella tissue dissemination and triggering of the immune
response. Of note, the mechanisms of Salmonella entry into M-cells
appear to be important for the distribution of bacteria in tissues
and activation of immune cells [72]. It has also been observed that
different serovars of Salmonella use distinct mechanisms for M-cells
transit. For example, S. Typhi traverses the murine epithelium via
M-cells without causing M-cell destruction, followed by the rapid
clearance of bacteria from Peyer patches, whereas SPI-1 T3SS-
dependent invasion of M-cells by S. Typhimurium is accompanied
by M-cell destruction, bacterial replication in Peyer’s patches and
robust activation of the mucosal immune response [72,73]. Thus,
in addition to the interaction with dendritic cells, allelic variations
in FimH may have a significant effect on bacterial uptake by M-
cells.
Somewhat unexpectedly, we discovered that some isolates of
host-adapted serovars Choleraesuis and Paratyphi B carry variants
of FimH that do not bind to mannose. Mannose non-binding type
1 fimbriae have been previously described for Salmonella in serovar
Gallinarum (biovars Gallinarum and Pullorum), some isolates of
Paratyphi B and Dublin, and were originally referred to as type 2
fimbriae based on the same morphology and antigenic properties
as type 1 fimbriae but with an inability to cause mannose-sensitive
hemagglutination [32,74]. More recently, studies in S. Gallinarum
revealed that non-hemagglutinating fimbriae represent type 1
fimbriae that have lost the ability to bind to mannose due to a
single point mutation (T56I) in FimH [54]. However, it was also
shown that although FimH of S. Gallinarum does not bind to
murine dendritic cells or other mammalian eukaryotic cells, it does
mediate efficient adhesion to chicken leukocytes in vitro and, and
most recently, promote systemic dissemination of bacteria in chick
model [53,75]. These results indicate that FimH of these avian-
adapted serovars of Salmonella can be functionally active and
potentially determine Salmonella host-specificity. Consistent with
these findings is the fact that S. Gallinarum FimH (Gal1 and Gal2
strains, Figure 5) has accumulated extra mutations in addition to
the original mutation in S. Pullorum (T56I) that cause complete
inactivation of FimH. The additional mutations could result in a
fine-tuning of some non-mannose type of receptor of as yet
unknown identity. Thus, although we did not detect adhesion of S.
Choleraesuis or S. Paratyphi B non-binding FimH variants to
human epithelial (Hep-2) cells and murine macrophages
(RAW264.7), we cannot exclude the possibility that they are
active towards a different type of eukaryotic cell or cells of different
host origin.
On the other hand, it is possible that the non-binding phenotype
is adaptive per se (i.e., conferring a loss-of-function) for the invasive
strains. Recent whole-genome comparative analyses revealed that
host-adapted) serovars of Salmonella have undergone extensive
genome degradation [6,7,23,24], with a high proportion of deleted
genes or pseudogenes. Many of these pseudogenes are derived
from genes of systemically non-invasive Salmonella that encode
proteins important for intestinal colonization and intestinal
persistence, including many different types of fimbriae. It has
been suggested that gene silencing by pseudogene formation along
with other ‘loss of function’ mutations allows host-adapted
Salmonella to shed genes that are no longer needed in the systemic
niche [7]. However, the footprint of strong positive selection for
loss of function in FimH indicates that it is not removed only on a
‘‘use-it-or-lose-it’’ basis, but that the inactivation of FimH in
invasive serovars might be adaptive for these bacteria because a
functional adhesin presents a liability in the course of systemic
infection. This hypothesis is in agreement with the observation
that, upon oral infection of mice, a non-fimbriated fim mutant of S.
Typhimurium results in significantly higher mortality than wild-
type bacteria expressing type 1 fimbriae [76]. Similarly, non-type 1
fimbriated E. coli were selected during the course of experimentally
induced bacteremia [77,78] suggesting that attenuation of type 1
fimbrial function could be beneficial for systemic infection.
In any event, the non-binding phenotype appears to be
evolutionarily linked to the highly adhesive phenotype. Indeed,
in addition to both being common in systemically invasive strains,
in two of three cases the high-binding variant was evolutionarily
intermediate to the non-binding phenotype. On the other hand,
among eight mutations leading to the high-binding phenotype of
FimH in S. Typhi, two mutations resulted in a non-binding
phenotype of FimH when tested separately, suggesting that some
of the evolutionary intermediates of the human-adapted FimH
could be non-binding. However, it remains to be understood how
this interplay between seemingly functionally opposite phenotypes
could lead to the emergence of systemically-invasive Salmonella
from systemically non-invasive serovars. Currently, the emergence
of systemically invasive non-typhoidal Salmonella (iNTS) strains
uniquely associated with invasive diseases in humans has become a
serious health problem in Africa [23]. Whole-genome sequencing
of iNTS S. Typhimurium strain D23580 associated with these
infections revealed that similarly to the host-adapted Salmonella this
strain has undergone evolutionary changes characterized by
pseudogene formation and chromosomal deletions. Analysis of
fimH from D23580 strain and also the Salmonella serogroup B C-24
(Thm5) isolate from our study (with a documented clinical history
of recurrent gastroenteritis/typhoid fever) showed that these
strains carry the low-adhesive variant of the FimH. This indicates
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in earlier stages of adaptive evolution as invasive pathogens.
After orally infecting mice with recombinant Salmonella, we did
not observe an effect of FimH mutations on bacterial burdens in
the liver and spleen. However, these experiments involved only a
single inoculum size and a single bacterial strain background (S.
Typhimurium) constitutively expressing a plasmid copy of fimH
used to infect a single host (BALB/c). One possible explanation of
these results could be that the experiment requires most specific
settings, e.g. the specific animal-host. In light of recently published
findings [75], host-specificity appears to be important factor in the
relevance of FimH association with Salmonella pathogenicity in
experimental models. In the chick model, clear differences were
observed in the virulence of avian adapted Salmonella Gallinarum
with an endogenous variant of FimH and S. Gallinarum
expressing mannose-sensitive FimH from S. Enteritidis. However,
similar studies performed in mice showed no difference in disease
for these bacteria [79]. Thus, to investigate the physiological
significance of adaptive FimH variants and, in particular, their
pathoadaptive role, more detailed future studies will be required.
S. enterica possess a wide repertoire of fimbrial and nonfimbrial
adhesins that contribute to the adhesion and the pathogenicity
[80,81,82,83,84,85], with some of them differently distributed
between serovars. Our studies on the mannose-specific type 1
fimbrial adhesin present in all Salmonella serovars demonstrate that
point mutations in the FimH are acquired under positive selection
and, thus, have functional consequences with an adaptive
significance. However, although the FimH adhesin is the primary
fimbrial subunit responsible for mannose binding, other type 1
fimbrial proteins and/or bacterial components can affect fimbriae
expression and the adhesion pattern [48,49,86]. In addition,
recently available full-genome sequences for different Salmonella
serovars revealed the presence of potential SNP mutations and
pseudogenes in fim structural genes and regulatory sequences
raising questions about their possible influence on FimH-
dependent binding [6,24,87]. Here, by the examination of
mannose-dependent binding of wild type Salmonella we show that
the vast majority of strains tested in our study produced type 1
fimbriae and the pattern of mannose-binding by these wild-type
Salmonella corresponded well to the binding mediated by their
FimH variants expressed in an isogenic recombinant system.
These results are consistent with a previous report [32] describing
type 1 fimbriae in 1444 isolates (149 serovars) of Salmonella enterica
where most strains of most serovars were found to be fimbriated
and possess mannose-dependent hemagglutinating and adhesive
properties. In our study, however, some differences in fimbriation
level were observed between wild-type strains, and some of the
strains (S. Paratyphi A and S. Sendai) appeared to produce no
fimbriae, even upon serial passage in conditions inducing type 1
fimbriae expression. Interestingly, such non-fimbriated isolates
were also observed previously in Paratyphi A and Sendai serovars
as well as in a portion of other serovars. This might suggest that
potential loss-of-function mutations in other type 1 fimbrial genes
or/and regulatory sequences could be responsible for the
abrogation of type 1 fimbriae expression. However, the presence
and role of these mutations/pseudogenes remain to be elucidated.
While FimH represents only one of many virulence traits, our
studies clearly highlight the importance of investigating the
physiological role of naturally-occurring mutations at the level of
single nucleotide polymorphisms in genes shared by all Salmonella
serovars because those mutations, in addition to horizontal gene
transfer and gene loss, are likely to make a significant contribution
to the adaptive evolution of Salmonella host adaptation and
virulence.
Materials and Methods
Ethics statement
This study was carried out in accordance with the recommen-
dations in the Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health. The protocol was reviewed
and approved by the University of Washington Institutional
Animal Care and Use Committee (Office of Laboratory Animal
Welfare assurance number: A3464-01).
Bacterial strains and knockouts
Salmonella strains used in this study are listed in Table 1. The
collection included 45 isolates of S. enterica subspecies I (22
serovars) and 11 isolates of S. enterica subspecies II–VI. The strains
were routinely grown overnight in LB (Luria-Bertani) broth
without shaking. The non-fimbriated fimH mutants of S.
Typhimurium strains SL1344H3 and LBH4 [38,87] were used
as hosts for recombinant plasmids encoding different FimH
variants or fimHD.pISF255b plasmid with the fimH deletion
(supplementary material Table S1). Transformed bacteria were
cultured in SB (Super Broth) supplemented with 30 mg/ml
chloramphenicol and 50 mg/ml kanamycin. All bacteria used in
the adhesion assay were serially subcultured without shaking at
37uC for optimal expression of type 1 fimbriae. Also, for the
biosafety reason, the aroA mutant of wild-type S. Typhi JSG624
(Typ4) was used in the adhesion assay. An aroA deletion mutant of
S. Typhi JSG624 was constructed using l red recombinase and
primers TYP9 TYAROAP1 CTGACGTTACAACCCATCG-
CGCGGGTCGATGGCGCCATTAgtgtaggctggagctgcttc and
TYP10- CGTACTCATCCGCGCCAGTTGTTCGAAATAAT-
CAGGGAACcatatgaatatcctccttag as described by Datsenko and
Wanner (2000). Escherichia coli DH5a, used for recombinant DNA
manipulations, were cultured in SB broth supplemented with
appropriate antibiotics as indicated.
fimH sequencing and cloning
The fimH and three housekeeping genes (aroC, hisD and thrA) were
PCR-amplified from various strains of S. enterica using genomic
DNA as a template. The primers for fimH amplification were:
fimH59-CAGGCGATTACGATAGCC-39 and fimH39-ATC-
CACCACGTTACCGCGC-39; and primers for housekeeping
genes were as described at http://mlst.ucc.ie/mlst/dbs/Senterica.
PCR products were purified after separation in 1% agarose gel on
QIAquick column (Qiagen) and sequenced using BigDye Termi-
nator v3.1 Cycle Sequencing Kit (Applied Biosystems).
For cloning, the fimH alleles of interest were PCR-amplified
from genomic DNA using fimH-XbaI-F 59-CTCTCTAGATG-
TATCCGTCCGGCGTC and fimH-SpeI-R 59-GAGAC-
TAGTTTAATCATAATCGACTCG-39 primers, XbaI/SpeI di-
gested and ligated into pISF255b [55]. The resulting plasmids
carrying different S. enterica fimH alleles are listed in Table S1
(supplemental material).
Site-directed mutagenesis
The different mutations were introduced into fimH by PCR
using the Quick-Change mutagenesis kit (Stratagene). pISF255b
carrying fimH from S. Typhimurium SL1344 was used as a
template. The mutagenic pairs of primers are listed in Table S2
(supplemental material). Sequencing of fimH was performed to
confirm introduced mutations.
Phylogenetic analysis
PhyML 3.0 [88] was used to generate the maximum-likelihood
based DNA phylograms of fimH and concatenated MLST loci,
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under GTR substitution model. The nucleotide sequences were
aligned using ClustalW with default settings [89]. Zonal Phylogeny
(ZP) analysis and associated statistics were performed using Zonal
Phylogeny Software (ZPS) [58]. The maximum likelihood (ML)
phylograms as implemented in ZPS were generated by PAUP*
4.0b using the general time reversible (GTP) substitution model
with codon-position specific estimated base frequencies [90].
Sequence diversity was measured by the average pairwise diversity
index (p) and the rates of nonsynonymous (dN) and synonymous
(dS) mutations [91] using MEGA version 4 [92]. Analysis of
statistical significance was performed using the z-test for p and
dN/dS values [93]. The presence of structural hotspot mutations
was determined using ZPS.
Static adhesion assay
FimH-dependent bacterial adhesion under static condition was
analyzed as described previously [94]. Briefly, immulon 4HBX 12
well strips (Thermo Electron Corp.) were coated with 20 mg/ml
Man-BSA, yeast mannan, RNaseB or rabbit anti-FimH
SE
antibody (diluted 1:500), and quenched with 0.1% BSA in PBS.
S. Typhimurium LBH4 expressing different FimH variants were
grown overnight with 0.33 mM [methyl-
3H]-thymidine (PerkinEl-
mer Life Sciences, Inc.), washed with PBS and then added to each
well at 100 ml volume and OD540=2. Plates were washed with
PBS and radioactivity for each well was counted with a
scintillation counter (MP Biomedicals). The number of bound
bacteria was determined from calibration curves. For inhibition,
bacterial binding was tested in the presence of 50 mM methyl-D-
mannopyranoside (a-mm).
Some adhesion experiments were performed without
3H-
bacteria labeling. Instead, bacteria bound to the ligands in
microtiter plates were dried and then stained with 0.1% crystal
violet for 10 min at room temperature. After several washes with
water, 100 ml of 50% ethanol were added to each well and after
dye solubilization the absorbance at a wavelength of 600 nm were
measured.
Parallel plate flow chamber experiment
Binding under flow conditions was performed using parallel
plate flow chambers as described previously [55]. Briefly, 35-mm
polystyrene cell culture dishes (Corning, Inc.) were coated with
Man-BSA (200 mg/ml), and a parallel plate flow chamber (2.5
(long)60.25 cm (wide)6250 mm (high), GlycoTech) was assembled
on the culture dish. The entire assembly was then mounted on a
Nikon TE2000-E microscope with a 106phase-contrast objective
and connected to a high resolution CCD Cascade camera (Roper
Scientific, Inc.). Bacteria in 0.2% BSA/PBS were flowed into the
chamber at different flow rates using a Warner Instruments
syringe pump. Bacterial binding to the surface was recorded for
4 min and analyzed using MetaView video acquisition software
(Universal Imaging Corp., PA).
Cell-adhesion and invasion assays
S. Typhimurium SL1344H3 expressing different FimH variants
were incubated with monolayers of Hep-2 or RAW 264.7 cells at a
multiplicity of infection of 25:1. Bacteria were allowed to interact
with the cells for 1 h at 37uCi n5 %C O 2. The cells were then
washed five times with DMEM and lysed with 1% Triton (Sigma)
in PBS, or for invasion studies, incubated with DMEM containing
100 mg/ml gentamicin for 1 h at 37uCi n5 %C O 2. After
antibiotic treatment the cells were washed three times with
DMEM and lysed with 1% Triton. The number of CFU in each
well was quantified by plating serial dilutions of cell lysates on LB
plates.
Mouse virulence assays
S. Typhimurium strains expressing different FimH variants
from S. Typhimurium SL1344 (Thm1, low-binding), S. Typhi
(Typ1, high-binding), and S. Choleraesuis (Chl1, inactive) were
administered orally to 6–8 week-old BALB/c mice (Taconic
Farms). The fimH genes were expressed from stable plasmid vector
pRB3-273C [95]. Bacteria were grown overnight without shaking
in SB broth supplemented with 30 mg/ml chloramphenicol,
washed and suspended in sterile PBS (pH 7.0) to a final
concentration of 10
7 colony-forming units (CFU) per 25 ml. Food
and water were withheld from the mice for 4 hours before bacteria
were administered atraumatically from a pipet tip. Mice were
sacrificed after 7 days for liver and spleen removal and
homogenization in sterile PBS. Serial dilutions of tissue home-
genates were plated onto LB agar with or without ampicillin to
quantitate CFU per organ.
List of accession/id numbers for genes mentioned in the
text
EU445777- fimH of S. Typhimurium AJB3
L19338.1 - fimH of S. Typhimurium LB5010
FN424405- fimH of S. Typhimurium D23580
AY486389 - fimH of S. Gallinarum 589/02
AM933173 - fimH of S. Gallinarum 287/91
NC_012125 - fimH of S. Paratyphi C 49 [RKS 4594]
aroA gene id: 1068996
Supporting Information
Figure S1 Static adhesion of S. Typhimurium LBH4
expressing different variants of FimH to mannose-
containing substrates. Binding of
3H-labled bacteria to
Man1 (Man-BSA) and Man5 (RNaseB) was determined as
described in ‘Materials and Methods’. Data are the means 6
SD of triplicates from one representative experiment of three
experiments that were performed.
(TIF)
Figure S2 Static adhesion of representative wild-type
and recombinant S. enterica to mannose-containing
substrates. Binding of wild-type (A) and recombinant (B) S.
enterica strains to Man1 (yeast mannan, red), Man5 (RNaseB, blue)
and anti-FimH
SE antibody (grey). Attached bacteria were stained
with crystal violet and the adhesion was quantified by measuring
absorbance at 600 nm. Data are the means 6 SD of triplicates
from one representative experiment of three performed. The strain
tags of systemically non-invasive serovars are in black and the
invasive serovars in red.
(TIF)
Figure S3 Man1/Man5 binding ratio calculated for
representative wild-type and recombinant strains of S.
enterica. Data are the means 6 SD of triplicates from one
representative experiment of three performed. The strain tags of
systemically non-invasive serovars are in black and the invasive
serovars in red. ND, not determined.
(TIF)
Figure S4 Bacterial accumulation on Man1-coated sur-
faces in the parallel plate flow chamber. Bacterial binding
to Man-BSA under different shear conditions was recorded for
4 min. Data are the means of two independent experiments.
(TIF)
Pathoadaptive FimH Mutations in Salmonella
PLoS Pathogens | www.plospathogens.org 13 June 2012 | Volume 8 | Issue 6 | e1002733Figure S5 Effects of point mutations on binding pheno-
type of S. enterica FimH. Static adhesion of
3H-labeled
bacteria to Man1 (Man-BSA, red), Man5 (RNaseB, blue) and anti-
FimH
SE antibody (grey). Data are the means 6 SD of triplicates
from one representative experiment of three performed.
(TIF)
Table S1 List of plasmids.
(RTF)
Table S2 List of primers.
(RTF)
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